BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35092757)

  • 1. DL0805-1, a novel Rho-kinase inhibitor, attenuates lung injury and vasculopathy in a rat model of monocrotaline-induced pulmonary hypertension.
    Chen D; Yuan T; Chen Y; Zhang H; Niu Z; Fang L; Du G
    Eur J Pharmacol; 2022 Mar; 919():174779. PubMed ID: 35092757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vasorelaxant mechanisms of a Rho kinase inhibitor DL0805 in rat thoracic aorta.
    Gong L; Peng J; Fang L; Xie P; Si K; Jiao X; Wang L; Du G
    Molecules; 2012 May; 17(5):5935-44. PubMed ID: 22609784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel hypertensive crisis rat model established by excessive norepinephrine infusion and the potential therapeutic effects of Rho-kinase inhibitors on it.
    Yuan TY; Chen D; Chen YC; Zhang HF; Niu ZR; Jiao XZ; Xie P; Fang LH; Du GH
    Biomed Pharmacother; 2019 Jan; 109():1867-1875. PubMed ID: 30551442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Protective Effect of DL0805 Derivatives on Pulmonary Artery Cells and the Underlying Mechanisms Study.
    Yuan T; Zhang H; Chen Y; Jiao X; Xie P; Fang L; Du G
    Curr Vasc Pharmacol; 2017; 15(5):469-476. PubMed ID: 28155615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of combined therapy with a Rho-kinase inhibitor and prostacyclin on monocrotaline-induced pulmonary hypertension in rats.
    Tawara S; Fukumoto Y; Shimokawa H
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):195-200. PubMed ID: 17703136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats.
    Abe K; Shimokawa H; Morikawa K; Uwatoku T; Oi K; Matsumoto Y; Hattori T; Nakashima Y; Kaibuchi K; Sueishi K; Takeshit A
    Circ Res; 2004 Feb; 94(3):385-93. PubMed ID: 14670839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilatory effect of a novel Rho-kinase inhibitor, DL0805-2, on the rat mesenteric artery and its potential mechanisms.
    Yuan TY; Yan Y; Wu YJ; Xu XN; Li L; Jiao XZ; Xie P; Fang LH; Du GH
    Cardiovasc Drugs Ther; 2014 Oct; 28(5):415-24. PubMed ID: 25086815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats.
    Jiang BH; Tawara S; Abe K; Takaki A; Fukumoto Y; Shimokawa H
    J Cardiovasc Pharmacol; 2007 Feb; 49(2):85-9. PubMed ID: 17312448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DL0805-2, a novel indazole derivative, relaxes angiotensin II-induced contractions of rat aortic rings by inhibiting Rho kinase and calcium fluxes.
    Yuan TY; Chen YC; Zhang HF; Li L; Jiao XZ; Xie P; Fang LH; Du GH
    Acta Pharmacol Sin; 2016 May; 37(5):604-16. PubMed ID: 27041459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat.
    Badejo AM; Dhaliwal JS; Casey DB; Gallen TB; Greco AJ; Kadowitz PJ
    Am J Physiol Lung Cell Mol Physiol; 2008 Nov; 295(5):L828-36. PubMed ID: 18689606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
    Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
    Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
    Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib attenuates monocrotaline pulmonary hypertension and has potent vasodilator activity in pulmonary and systemic vascular beds in the rat.
    Pankey EA; Thammasiboon S; Lasker GF; Baber S; Lasky JA; Kadowitz PJ
    Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1288-96. PubMed ID: 23997103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
    Li FH; Xia W; Li AW; Zhao CF; Sun RP
    Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of pulmonary hypertension secondary to left ventricular dysfunction in the rat by Rho-kinase inhibitor fasudil.
    Dai ZK; Wu BN; Chen IC; Chai CY; Wu JR; Chou SH; Yeh JL; Chen IJ; Tan MS
    Pediatr Pulmonol; 2011 Jan; 46(1):45-59. PubMed ID: 20717937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.
    Yasuda T; Tada Y; Tanabe N; Tatsumi K; West J
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L667-74. PubMed ID: 21856816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia.
    Ziino AJ; Ivanovska J; Belcastro R; Kantores C; Xu EZ; Lau M; McNamara PJ; Tanswell AK; Jankov RP
    Pediatr Res; 2010 Feb; 67(2):177-82. PubMed ID: 19858775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fasudil reverses monocrotaline-induced pulmonary hypertension in rats].
    Jiang H; Guan RJ; Wang HY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):239-44. PubMed ID: 23879951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Rho kinase inhibitor azaindole-1 has long-acting vasodilator activity in the pulmonary vascular bed of the intact chest rat.
    Pankey EA; Byun RJ; Smith WB; Bhartiya M; Bueno FR; Badejo AM; Stasch JP; Murthy SN; Nossaman BD; Kadowitz PJ
    Can J Physiol Pharmacol; 2012 Jul; 90(7):825-35. PubMed ID: 22591047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasudil reversed MCT-induced and chronic hypoxia-induced pulmonary hypertension by attenuating oxidative stress and inhibiting the expression of Trx1 and HIF-1α.
    Liu M; Wang Y; Zheng L; Zheng W; Dong K; Chen S; Zhang B; Li Z
    Respir Physiol Neurobiol; 2014 Sep; 201():38-46. PubMed ID: 24973470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.